The use of snake venom toxins as tools to study platelet receptors for collagen and von Willebrand factor

Haemostasis

Volumn 31, Issue 3-6, 2001, Pages 155-172

  Andrews, Robert K ^e   Kamiguti, Aura S ^b   Berlanga, Oscar ^a   Leduc, Mireille ^c   Theakston, R David G ^d   Watson, Steve P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c INSTITUT PASTEUR   (France)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Botrocetin; C type lectin; Collagen; Convulxin; GPIb IX V; GPVI; Metalloproteinase; Snake toxin; von Willebrand factor

Indexed keywords

COLLAGEN; FIBRINOGEN RECEPTOR; INTEGRIN; LECTIN; METALLOPROTEINASE; SNAKE VENOM; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR; CELL SURFACE RECEPTOR; COLLAGEN RECEPTOR; VON WILLEBRAND FACTOR RECEPTOR;

ARTICLE; BLOOD CLOTTING; CELL INTERACTION; CELL SURFACE; HEMOSTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SNAKE; THROMBOCYTE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW;

ANIMALS; COLLAGEN; HEMOSTASIS; HUMANS; MODELS, MOLECULAR; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; RECEPTORS, COLLAGEN; SNAKE VENOMS; VON WILLEBRAND FACTOR;

EID: 0035742227     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048059     Document Type: Article

References (94)

1. Snake venoms and the hemostatic system
2. Two distinct classes of carbohydrate-recognition domains in animal lectins
3. The asialoglycoprotein receptor: A model for endocytic transport receptors
4. Physical characterization and crystallization of the carbohydrate-recognition domain of a mannose-binding protein from rat
5. Structure of a C-type mannose-binding protein complexed with an oligosaccharide
6. Two distinct families of animal lectins: Speculation on their raison d'étre
7. Cloning of subunits of convulxin, a collagen-like platelet-aggregating protein from Crotalus durissus terrificus venom
8. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca
9. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1
10. Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains
11. Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: Implication of central loop swapping based on deletion in the linker region
12. Crystal structure of the von Willebrand factor modulator botrocetin
13. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex
14. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus
15. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms
16. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors
17. Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: Expression of ligand-induced binding site on beta 3 subunit
18. Hemorrhagic metalloproteinases from snake venoms
19. The complete amino acid sequence of the high molecular mass hemorrhagic protein HR1B isolated from the venom of Trimeresurus flavoviridis
20. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararacavenom. Insights into the disintegrin gene family
21. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: Evidence for signal, zymogen, and disintegrin-like structures
22. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain
23. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
24. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation
25. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain
26. Identification of 50 kDa snake venom proteins which specifically inhibit platelet adhesion to collagen
27. Jararhagin ECD-containing disintegrin domain: Expression in Escherichia coliand inhibition of the platelet-collagen interaction
28. Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom metalloproteinase, atrolysin A
29. The vascular biology of the glycoprotein Ib-IX-V complex
30. Snake venom modulators of platelet adhesion receptors and their ligands
31. A revised model of platelet aggregation
32. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor
33. Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor
34. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib
35. Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib
36. Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus,also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction
37. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation
38. Alboaggregins A and B. Structure and interaction with human platelets
39. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets
40. The snake venom toxin alboaggregin-A activates glycoprotein VI
41. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib
42. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper) stimulates platelets by binding to alpha 2beta 1 integrin and glycoprotein Ib, activating Syk and phospholipase Cgamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor
43. Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha
44. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor Fcgam-maRIIA on the platelet plasma membrane
45. Role of Fc receptor-chain in platelet glycoprotein Ib-mediated signaling
46. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin
47. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding
48. Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding
49. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III
50. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding
51. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin
52. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus
53. Update on collagen receptors: Is the two-site, two-state model still valid?
54. The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen
55. Platelet collagen receptors
56. Collagen receptor in platelets: Extending the role of the ITAM
57. Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom ofCrotalus durissus cascavella
58. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: Specific crossed desensitisation with collagen
59. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor
60. Convulxin induces platelet activation by a tyrosine-kinase dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLCγ2, independently of integrin αIIβ3
61. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcαR and the natural killer receptors
62. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation
63. Evidence against a direct role of the integrin alpha2beta1 in collagen-induced tyrosine phosphorylation in human platelets
64. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets
65. Convulxin binding to platelet receptor GPVI: Competition with collagen related peptides
66. Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin
67. Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets: Evidence for the involvement of Src family kinases
68. Events underlying platelet aggregation to the GPVI agonist convulxin
69. Trimucytin: A collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom
70. Alboluxin, a snake C-type lectin from Trimeresurus albolabrisvenom is a potent platelet agonist acting via both GPIb and GPVI
71. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI
72. Evidence for two distinct epitopes within collagen for activation of murine platelets
73. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist
74. Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostomai (Malayan pit viper): Synergistic and non-covalent interaction between its subunits
75. Alpha2beta1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen
76. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhagin
77. Proteolytic cleavage of the beta1 subunit of platelet alpha2beta1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72
78. A peptide inhibiting the collagen binding function of integrin alpha2I domain
79. 'RKKH' peptides from the snake venom metalloproteinase of Bothrops jararaca bind near the metal ion-dependent adhesion site of the human integrin alpha(2)I-domain
80. Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib
81. Signal transduction pathways mediated by glycoprotein la/lla in human platelets: Comparison with those of glycoprotein VI
82. Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, integrin alpha 2beta 1)
83. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage
84. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom
85. Functional and sequence characterization of agkicetin, a new glycoprotein Ib antagonist isolated from Agkistrodon acutus venom. offf2p4
86. Alboaggregin-B: A new platelet agonist that binds to platelet membrane glycoprotein Ib
87. Primary structure of alboaggregin-B purified from the venom ofTrimeresurus albolabris
88. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox
89. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom
90. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress
91. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib
92. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation
93. Purification and characterisation of kaouthiagin, a von Willebrand factor-binding and cleaving metalloproteinase from Naja kaouthia cobra venom